Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature
- 26 February 2013
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 172 (7) , 927-945
Abstract
The 22q11.2 deletion is the most frequent interstitial deletion in humans and presents a wide phenotypic spectrum, with over 180 clinical manifestations described. Distinct studies have detected frequencies of the deletion ranging from 0 % to 75 %, depending on the studied population and selection criteria adopted. Due to the lack of consensus in this matter, several studies have been conducted aiming to define which patients would be eligible for screening; however, the issue is still up for debate. In order to contribute to the delineation of possible clinical and dysmorphologic guidelines to optimize decision making in the clinical setting, 194 individuals with variable features of the 22q11.2 deletion syndromes (22q11.2DS) were evaluated. Group I, clinical suspicion of 22q11.2DS with palatal anomalies; Group II, clinical suspicion without palatal anomalies; Group III, cardiac malformations associated with the 22q11.2DS; and Group IV, juvenile-onset schizophrenia. Multiplex ligation-dependent probe amplification was used for screening the 22q11.2 deletion, which was detected in 45 patients (23.2 %), distributed as such: Group I, 35/101 (34.7 %); Group II, 4/18 (22.2 %); Group III, 6/52 (11.5 %); and Group IV, 0/23 (0 %). Clinical data were analyzed by frequency distribution and statistically. Based on the present results and on the review of the literature, we propose a set of guidelines for screening patients with distinct manifestations of the 22q11.2DS in order to maximize resources. In addition, we report the dysmorphic features which we found to be statistically correlated with the presence of the 22q11.2DS.Keywords
This publication has 83 references indexed in Scilit:
- Rethinking schizophreniaNature, 2010
- The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disordersInternational Journal of Developmental Neuroscience, 2010
- Prevalence of 22q11.2 microdeletion in 146 patients with cardiac malformation in a referral hospital of North IndiaBMC Medical Genetics, 2010
- Cardiovascular Anomalies Associated With Chromosome 22q11.2 Deletion SyndromeThe American Journal of Cardiology, 2010
- Microduplication 22q11.2: A new chromosomal syndromeEuropean Journal of Medical Genetics, 2009
- Detailed analysis of 22q11.2 with a high density MLPA probe setHuman Mutation, 2007
- Microdeletion and microduplication 22q11.2 screening in 295 patients with clinical features of DiGeorge/Velocardiofacial syndromeAmerican Journal of Medical Genetics Part A, 2006
- Comparative study of three diagnostic approaches (FISH, STRs and MLPA) in 30 patients with 22q11.2 deletion syndromeClinical Genetics, 2005
- Presenting phenotype in 100 children with the 22q11 deletion syndromeEuropean Journal of Pediatrics, 2004
- Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: A prospective studyEuropean Journal of Pediatrics, 1995